Splenz Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2014.
2014 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Splenz Pharmaceuticals Private Limited

Splenz Pharmaceuticals Private Limited, a active private limited company, was established on 27 May 2014 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52599PN2014PTC151314. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹2.00 M.

It upholds a compliant status. Its leadership includes Ashish Bhagwan Bhagat (Director), Jitendra Ashok Fasate (Director). Past directors included Padmakumar Poduvattil, Shylaja Padmakumar, Ashish Bhagwan Bhagat. It holds ₹5.99 M open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S. No. 1095, Milkat. No. 3672, Near Sakal Press, Trimurti Nagar, Wadki,, Pune, Maharashtra, 412308.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52599PN2014PTC151314

  • Registration Number

    151314

  • Incorporation Date

    27 May 2014

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹2.00 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 2.00 M
  • Company Age 11 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.99 M
  • Satisfied Charges ₹ 5.00 M
  • Revenue Growth **** 29.48%
  • Profit Growth **** 77.22%
  • Ebitda **** 2.22%
  • Net Worth 19.61%
  • Total Assets **** 10.98%
Company report

Splenz Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Splenz Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Splenz Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashish Bhagwan Bhagat Director 23 Sep 2015 Current
Jitendra Ashok Fasate Director 23 Sep 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Aug 2020 Past
Pramod Abcsdd Director 31 Mar 2021 Past
Pramod Abcsdd Additional Director 31 Dec 2015 Past
Pramod Abcsdd Additional Director 31 Dec 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Splenz Pharmaceuticals.

Splenz Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.48% increase. The company also saw a substantial improvement in profitability, with a 77.22% increase in profit. The company's net worth Soared by an impressive increase of 19.61%.

Splenz Pharmaceuticals revenue growth over time
Splenz Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 29.48%
*******
*******
*******
*******
Revenue from Operations
*******
 29.44%
*******
*******
*******
*******
Total Assets
*******
 10.98%
*******
*******
*******
*******
Profit or Loss
*******
 77.22%
*******
*******
*******
*******
Net Worth
*******
 19.61%
*******
*******
*******
*******
EBITDA
*******
 2.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Splenz Pharmaceuticals?

In 2022, Splenz Pharmaceuticals had a public holding of 14.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,990,000.00

Satisfied Charges

₹5,000,000.00

Charges Breakdown by Lending Institutions
  • The South Indian Bank Limited : 0.60 Cr
Latest Charge Details
Date Lender Amount Status
03 Jan 2020 The South Indian Bank Limited ₹5.99 M Open
06 Dec 2014 Others ₹5.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Splenz Pharmaceuticals?

Unlock and access historical data on people associated with Splenz Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Splenz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Splenz Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Splenz Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Splenz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Splenz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.

  • Charges

    The activity A charge registered on 06 Dec 2014 via Charge ID 10535157 with Others was fully satisfied on 31 Jul 2020. was completed.

  • Charges

    A charge with The South Indian Bank Limited of Rs. 5.99 M registered on 03 Jan 2020 with Charge ID 100318836 was modified on 03 Jul 2020. was recorded as a recent event.

  • Charges

    A charge with The South Indian Bank Limited amounted to Rs. 5.99 M with Charge ID 100318836 was registered on 03 Jan 2020. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 5.00 M registered on 06 Dec 2014 with Charge ID 10535157 was modified on 10 Jul 2018. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Splenz Pharmaceuticals Private Limited?

The CIN of Splenz Pharmaceuticals Private Limited is U52599PN2014PTC151314.

Where is Splenz Pharmaceuticals Private Limited headquartered?

Splenz Pharmaceuticals Private Limited is headquartered at S. No. 1095, Milkat. No. 3672, Near Sakal Press, Trimurti Nagar, Wadki,, Pune, Maharashtra, 412308.

When was Splenz Pharmaceuticals Private Limited incorporated?

Splenz Pharmaceuticals Private Limited was incorporated on 27 May 2014.

Who are the current directors of Splenz Pharmaceuticals Private Limited?

The current directors of Splenz Pharmaceuticals Private Limited are

What is the primary industry of Splenz Pharmaceuticals Private Limited?

The primary industry of Splenz Pharmaceuticals Private Limited is Trade.

Is Splenz Pharmaceuticals Private Limited a listed company?

Splenz Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Splenz Pharmaceuticals Private Limited?

The authorized capital of Splenz Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹2.00 M.

What is the compliance status of Splenz Pharmaceuticals Private Limited?

The compliance status of Splenz Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available